cinnabarinic acid has been researched along with Allergic Encephalomyelitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allegrucci, M; Belladonna, ML; Bessede, A; Busceti, C; Fallarino, F; Fazio, F; Gargaro, M; Lionetto, L; Nicoletti, F; Notartomaso, S; Scarselli, P; Simmaco, M; Vacca, C; Volpi, C; Zappulla, C | 1 |
1 other study(ies) available for cinnabarinic acid and Allergic Encephalomyelitis
Article | Year |
---|---|
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.
Topics: Animals; Benzopyrans; Central Nervous System; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Agonists; Male; Mice; Mice, Inbred C57BL; Myelin Basic Protein; Myelin-Oligodendrocyte Glycoprotein; Myosin Type II; Nuclear Receptor Subfamily 1, Group F, Member 3; Oxazines; Peptide Fragments; Receptors, Metabotropic Glutamate; T-Box Domain Proteins; Th17 Cells; Time Factors; Transcription Factors | 2014 |